MicroRNA-30a-3p functions as a tumor suppressor in renal cell carcinoma by targeting WNT2

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNA (miR)-30a-3p's role in human cancers is known, but its function in renal cell carcinoma (RCC) is unclear.
• RCC is a significant global health concern, necessitating research into novel therapeutic targets.

Purpose of the Study:

• To investigate the expression and function of miR-30a-3p in renal cell carcinoma (RCC).
• To elucidate the potential anti-tumor role of miR-30a-3p and its underlying mechanism in RCC progression.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) to assess miR-30a-3p expression in RCC tissues and cell lines.
• In vitro cell assays (proliferation, migration, invasion) and in vivo tumor xenograft models to evaluate miR-30a-3p's functional impact.
• Bioinformatic analysis (TargetScan) and experimental validation to identify and confirm miR-30a-3p's direct target, Wnt2.

Main Results:

• miR-30a-3p expression was significantly down-regulated in RCC tissues compared to adjacent normal tissues.
• Ectopic expression of miR-30a-3p suppressed RCC cell proliferation, migration, and invasion in vitro, and inhibited tumor growth in vivo.
• Wnt2 was identified as a direct target of miR-30a-3p, and its re-expression restored RCC cell proliferation and invasion, confirming miR-30a-3p's inhibitory role.

Conclusions:

• miR-30a-3p acts as a tumor suppressor in renal cell carcinoma (RCC).
• The anti-tumor effects of miR-30a-3p in RCC are potentially mediated through the down-regulation of its direct target, Wnt2.
• miR-30a-3p represents a potential therapeutic target for managing RCC progression.